FEATURED NEWS

• HDA Statement on FDA Authorization of Johnson & Johnson COVID-19 Vaccine

  February 27, 2021

  HDA President and CEO Chester “Chip” Davis, Jr., released a statement regarding the U.S. Food and Drug Administration’s (FDA) granting of an Emergency Use Authorization (EUA) for the Johnson & Johnson (Janssen Biotech) COVID-19 vaccine candidate.

• AAOA Marks Three Years of Collaborative Efforts to Increase Rx Opioid Safety Awareness

  February 25, 2021

  February marks Allied Against Opioid Abuse’s (AAOA) third year of bringing together healthcare stakeholders to increase awareness about prescription opioid safety.

• HDA Named a 2021 "Best Place to Work in Virginia"

  February 1, 2021

  The Healthcare Distribution Alliance (HDA) was named one of the 100 “Best Places to Work in Virginia” by Virginia Business magazine and Best Companies Group. This is the ninth year that HDA has received this distinction.

• HDA Statement on Biden Administration Announcement of Increased COVID-19 Vaccine Supply

  January 26, 2021

  Following the Biden administration’s announcement of an increase in the supply of available vaccines for millions of Americans, Chester “Chip” Davis, Jr., President and CEO of the Healthcare Distribution Alliance (HDA), issued a statement.

• HDA Statement on COVID-19 Vaccine Distribution and Role of Distribution Industry

  January 22, 2021

  HDA President and CEO Chester “Chip” Davis, Jr., released the following statement in response to recent commentary related to the COVID-19 vaccination effort.